John F. Oram

15.2k total citations · 2 hit papers
115 papers, 11.9k citations indexed

About

John F. Oram is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, John F. Oram has authored 115 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Surgery, 59 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in John F. Oram's work include Cholesterol and Lipid Metabolism (71 papers), Peroxisome Proliferator-Activated Receptors (43 papers) and Drug Transport and Resistance Mechanisms (27 papers). John F. Oram is often cited by papers focused on Cholesterol and Lipid Metabolism (71 papers), Peroxisome Proliferator-Activated Receptors (43 papers) and Drug Transport and Resistance Mechanisms (27 papers). John F. Oram collaborates with scholars based in United States, United Kingdom and Japan. John F. Oram's co-authors include Ashley M. Vaughan, Jay W. Heinecke, E L Bierman, Chongren Tang, David P. Wade, Yutong Wang, Richard M. Lawn, Baohai Shao, Michael R. Garvin and J. R. Neely and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

John F. Oram

113 papers receiving 11.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

1999 611 citations Ashley M. Vaughan, John F. Oram et al. Journal of Clinical Investigation profile →
Myocardial utilization of carbohydrate and lipids

1972 402 citations J. R. Neely, Michael J. Rovetto et al. Progress in Cardiovascular Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John F. Oram United States	62	7.2k	5.3k	2.8k	2.6k	2.0k	115	11.9k
Nan Wang United States	52	8.0k 1.1×	5.6k 1.1×	3.7k 1.3×	2.0k 0.8×	2.3k 1.2×	91	12.4k
Gilles Lambert France	49	5.4k 0.8×	3.8k 0.7×	2.4k 0.9×	1.9k 0.7×	1.5k 0.8×	138	10.4k
John A. Glomset United States	50	4.5k 0.6×	6.6k 1.2×	1.2k 0.4×	2.3k 0.9×	1.9k 1.0×	85	13.3k
J L Goldstein United States	47	5.4k 0.8×	6.3k 1.2×	1.2k 0.4×	1.9k 0.7×	2.3k 1.2×	57	11.9k
Yves L. Marcel Canada	56	4.9k 0.7×	4.5k 0.9×	843 0.3×	3.5k 1.3×	2.1k 1.1×	155	10.8k
Kerry‐Anne Rye Australia	65	6.2k 0.9×	4.7k 0.9×	1.0k 0.4×	5.1k 1.9×	2.4k 1.2×	266	13.4k
H. Bryan Brewer United States	72	10.9k 1.5×	7.6k 1.4×	3.4k 1.2×	6.5k 2.5×	3.5k 1.8×	239	19.2k
Eran Leitersdorf Israel	41	5.2k 0.7×	2.8k 0.5×	1.2k 0.4×	2.5k 1.0×	1.5k 0.8×	152	8.9k
Linda K. Curtiss United States	67	5.1k 0.7×	4.8k 0.9×	1.3k 0.5×	2.8k 1.1×	1.9k 1.0×	190	15.0k
Liqing Yu United States	47	5.2k 0.7×	3.9k 0.7×	3.4k 1.2×	1.1k 0.4×	1.1k 0.6×	112	8.9k

Countries citing papers authored by John F. Oram

Since Specialization

Citations

This map shows the geographic impact of John F. Oram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Oram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Oram more than expected).

Fields of papers citing papers by John F. Oram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Oram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Oram. The network helps show where John F. Oram may publish in the future.

Co-authorship network of co-authors of John F. Oram

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Oram. A scholar is included among the top collaborators of John F. Oram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Oram. John F. Oram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Andrew, Priya Handa, Sanshiro Tateya, et al.. (2012). Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts. PLoS ONE. 7(3). e33917–e33917. 73 indexed citations

Becker, Lev, Sina A. Gharib, Angela D. Irwin, et al.. (2010). A Macrophage Sterol-Responsive Network Linked to Atherogenesis. Cell Metabolism. 11(2). 125–135. 65 indexed citations

Tang, Chongren & John F. Oram. (2009). The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1791(7). 563–572. 100 indexed citations

Shao, Baohai, Michael N. Oda, Tomáš Vaisar, John F. Oram, & Jay W. Heinecke. (2006). Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.. PubMed. 8(3). 198–205. 32 indexed citations

Buehner, Ulrike, John F. Oram, S. Elliot, A. Mallick, & A. Bodenham. (2006). Bonfils semirigid endoscope for guidance during percutaneous tracheostomy. Anaesthesia. 61(7). 665–670. 9 indexed citations

Chait, Alan, Chang Yeop Han, John F. Oram, & Jay W. Heinecke. (2005). Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. Journal of Lipid Research. 46(3). 389–403. 200 indexed citations

Oram, John F. & Jay W. Heinecke. (2005). ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease. Physiological Reviews. 85(4). 1343–1372. 430 indexed citations

Bergt, Constanze, Subramaniam Pennathur, Xiaoyun Fu, et al.. (2004). The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proceedings of the National Academy of Sciences. 101(35). 13032–13037. 381 indexed citations

Pennathur, Subramaniam, Constanze Bergt, Baohai Shao, et al.. (2004). Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species. Journal of Biological Chemistry. 279(41). 42977–42983. 229 indexed citations

10.

Lee, Jin, et al.. (2003). Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(3). G630–G641. 22 indexed citations

11.

Oram, John F.. (2002). ATP-binding cassette transporter A1 and cholesterol trafficking. Current Opinion in Lipidology. 13(4). 373–381. 121 indexed citations

12.

Oram, John F., Ashley M. Vaughan, & Roland Stocker. (2001). ATP-binding Cassette Transporter A1 Mediates Cellular Secretion of α-Tocopherol. Journal of Biological Chemistry. 276(43). 39898–39902. 142 indexed citations

13.

Oram, John F.. (2000). Tangier disease and ABCA1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1529(1-3). 321–330. 192 indexed citations

14.

Ranjbar, Shahin, Uma Bhattacharya, John F. Oram, E. J. Stott, & Neil Almond. (2000). Construction of infectious SIV/HIV-2 chimeras. AIDS. 14(16). 2479–2484. 2 indexed citations

15.

Wolfbauer, Gertrud, John J. Albers, & John F. Oram. (1999). Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1439(1). 65–76. 96 indexed citations

16.

Deeg, Mark A., et al.. (1997). High Density Lipoproteins Stimulate Mitogen-Activated Protein Kinases in Human Skin Fibroblasts. Arteriosclerosis Thrombosis and Vascular Biology. 17(9). 1667–1674. 40 indexed citations

17.

Mendez, Armando J., G.M. Anantharamaiah, Jere P. Segrest, & John F. Oram. (1994). Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.. Journal of Clinical Investigation. 94(4). 1698–1705. 169 indexed citations

18.

Oram, John F.. (1991). High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterolloaded fibroblasts.. Medical Entomology and Zoology. 11. 403–414. 2 indexed citations

19.

Oram, John F., et al.. (1988). Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation.. Journal of Biological Chemistry. 263(36). 19318–19323. 39 indexed citations

20.

Neely, J. R., Michael J. Rovetto, & John F. Oram. (1972). Myocardial utilization of carbohydrate and lipids. Progress in Cardiovascular Diseases. 15(3). 289–329. 402 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact